Kevin D. Bunker, Chief Operating Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 5,000 shares at $30.00 ($150K) on 2022-08-10, disclosed to the SEC on 2022-08-12.
Open-market sale of $150k ZNTL by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ZNTL | SELL | 2023-02-14 | $285K | — | Filing → |
| ZNTL | SELL | 2022-07-20 | $150K | — | Filing → |
| ZNTL | SELL | 2022-07-14 | $300K | — | Filing → |